Lung cancer innovations are not only extending lives but also enhancing the quality of life for patients, offering renewed ...

Sleeve resection Segmentectomy or wedge resection (for tumors smaller than 2 centimeters across ... “Surgery for non-small cell lung cancer,” “Treatment choices by stage for non-small ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

The FDA has approved the drug durvalumab for adults with limited-stage small-cell lung cancer (LS-SCLC) whose disease hasn’t ...

The identification of incidentally explanted lung cancer should not immediately rule out lung transplant in candidates with ...

Upon diagnosis, 80% of individuals already have stage 4 metastatic cancer ... announces the launch of the PoweRD 2 Cure ALK+ Lung Cancer TeamLab. This collaborative research team, made up of ...

The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), as a single agent, for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has ...

FDA approves AstraZeneca’s Imfinzi for limited-stage small cell lung cancer, cutting the risk of death by 27% in ... The ...

The agency granted approval to durvalumab for the treatment of a subset of patients with limited-stage small cell lung cancer ...

The approval of durvalumab, based on data from the phase 3 ADRIATIC study, offers a new standard of care for patients with ...